Skip to content
Biodatica
Start free

Harvard Pilgrim Health Care

Riverside, California

Filed/Approved
Sign in to watch

What changed

NIH R01 · $0.5M · The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection)

9mo agoGrant renewalSep 23, 2025Source filing (opens the source filing in a new tab)

Momentum

58no change

Momentum 58 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Filed/Approved

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    NA registered

    Jan 1, 2023

    Skin and Soft Tissue (SST) Infection · COMPLETED · sponsor: Harvard Pilgrim Health Care · INSPIRE Trial for Skin and Soft Tissue Infections

    ClinicalTrials.gov · NCT05423756 (opens the source filing in a new tab)

  2. Grant

    R01 · $500k · non-dilutive

    Aug 1, 2022

    UNIVERSITY OF CALIFORNIA-IRVINE · PI HUANG, SUSAN S. · AHRQ · award ends May 31, 2027 · The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection)

    NIH RePORTER · NIH RePORTER 11093397 (opens the source filing in a new tab)

  3. Trial

    PHASE4 registered

    May 1, 2017

    Staphylococcus Aureus · COMPLETED · sponsor: Harvard Pilgrim Health Care · Mupirocin-Iodophor ICU Decolonization Swap Out Trial

    ClinicalTrials.gov · NCT03140423 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources